Variable | Mortality from OC | Mortality from other causes | |||||
---|---|---|---|---|---|---|---|
Group size | Deaths | HR | (95% CI) | Deaths | HR | (95% CI) | |
Year of diagnosis | |||||||
1998─2002 | 115 | 84 | 1.00 | Ref. | 13 | 1.00 | Ref. |
2003─2007 | 149 | 106 | 1.17 | (0.86–1.59) | 12 | 1.16 | (0.45–2.99) |
2008─2011 | 157 | 86 | 0.97 | (0.69–1.37) | 9 | 1.13 | (0.39–3.27) |
Age at diagnosis (years) | |||||||
42─59 | 59 | 30 | 0.67 | (0.44–1.04) | 1 | 0.18 | (0.02–1.53) |
60─69 | 132 | 76 | 1.00 | Ref. | 9 | 1.00 | Ref. |
70─79 | 160 | 120 | 1.53 | (1.14–2.05) | 14 | 2.49 | (1.03–6.05) |
80─92 | 70 | 50 | 2.88 | (1.98–4.20) | 10 | 5.40 | (1.99–14.65) |
Duration of diabetes (years) | |||||||
0.5─ < 3 | 103 | 61 | 1.00 | Ref. | 11 | 1.00 | Ref. |
3─ < 6 | 100 | 70 | 1.31 | (0.91–1.90) | 3 | 0.35 | (0.09–1.36) |
6─ < 12 | 148 | 101 | 1.15 | (0.81–1.63) | 11 | 0.88 | (0.34–2.27) |
12─ < 34 | 70 | 44 | 0.98 | (0.61–1.57) | 9 | 1.20 | (0.42–3.44) |
Stage | |||||||
Local | 52 | 9 | 1.00 | Ref. | 9 | 1.00 | Ref. |
Advanced | 330 | 256 | 9.05 | (4.60–17.82) | 19 | 0.80 | (0.32–2.01) |
Unknown | 39 | 11 | 1.60 | (0.66–3.89) | 6 | 1.01 | (0.32–3.23) |
Pre-diagnostic statin use | |||||||
No | 235 | 162 | 1.00 | Ref. | 20 | 1.00 | Ref. |
Yes | 186 | 114 | 0.72 | (0.56–0.93) | 14 | 0.66 | (0.30–1.43) |
Pre-diagnostic ADM group | |||||||
Metformin | 77 | 46 | 1.15 | (0.74–1.79) | 5 | 1.85 | (0.44–7.73) |
Othera | 58 | 44 | 1.00 | Ref. | 4 | 1.00 | Ref. |
Metformin and othera | 100 | 67 | 1.21 | (0.82–1.80) | 6 | 1.19 | (0.32–4.38) |
Insulin | 82 | 59 | 1.49 | (0.96–2.30) | 7 | 1.61 | (0.42–6.18) |
None | 104 | 60 | 0.69 | (0.46–1.03) | 12 | 1.48 | (0.46–4.78) |